Regulating the safety of pharmaceuticals: The FDA, preemption, and the public's health

Lawrence O. Gostin

doi:10.1001/jama.2009.680

Regulating the safety of pharmaceuticals: The FDA, preemption, and the public's health

Lawrence O. Gostin

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2036-2037
Number of pages	2
Journal	JAMA
Volume	301
Issue number	19
DOIs	https://doi.org/10.1001/jama.2009.680
State	Published - May 20 2009
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2009.680

Cite this

@article{9768e630407f420faae660778326537f,

title = "Regulating the safety of pharmaceuticals: The FDA, preemption, and the public's health",

author = "Gostin, {Lawrence O.}",

year = "2009",

month = may,

day = "20",

doi = "10.1001/jama.2009.680",

language = "English (US)",

volume = "301",

pages = "2036--2037",

journal = "JAMA",

issn = "0098-7484",

publisher = "American Medical Association",

number = "19",

}

TY - JOUR

T1 - Regulating the safety of pharmaceuticals

T2 - The FDA, preemption, and the public's health

AU - Gostin, Lawrence O.

PY - 2009/5/20

Y1 - 2009/5/20

UR - http://www.scopus.com/inward/record.url?scp=65649128588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649128588&partnerID=8YFLogxK

U2 - 10.1001/jama.2009.680

DO - 10.1001/jama.2009.680

M3 - Comment/debate

C2 - 19454642

AN - SCOPUS:65649128588

SN - 0098-7484

VL - 301

SP - 2036

EP - 2037

JO - JAMA

JF - JAMA

IS - 19

ER -

Regulating the safety of pharmaceuticals: The FDA, preemption, and the public's health

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this